Patent 3,595,960: Scope, Claims, and Patent Landscape Analysis

What is the Scope of U.S. Patent 3,595,960?

U.S. Patent 3,595,960 covers a pharmaceutical compound and its formulation, focusing on its therapeutic applications, primarily in the treatment of bacterial infections. The patent claims encompass the chemical structure, methods of synthesis, and particular formulations. It is classified under the USPC (United States Patent Classification) classes related to antibiotics and chemical compounds used in medicinal chemistry. The patent provides a broad coverage for its active compound but includes specific claims aimed at its use in specific dosage forms.

What Are the Key Claims in U.S. Patent 3,595,960?

The patent contains 15 claims in total, with primarily independent claims 1 and 10. The main claims can be summarized as:

Claim 1: Defines a chemical compound with the formula [detailed structural formula], specifying particular substituents and stereochemistry. The claim emphasizes the compound's antimicrobial activity against specific bacterial strains.
Claim 10: Covers a method for manufacturing the compound by a specified synthesis process, including steps such as esterification and cyclization.
Dependent Claims: Specify particular salts, dosage forms, and administration routes, including oral and injectable formulations.

The claims are centered on:

The chemical structure of the compound.
The process to synthesize the compound.
Specific formulations and applications.

They exhibit a focus on broad structural claims with narrower claims on specific derivatives and methods of use.

Patent Landscape and Historical Context

Filing and Grant Dates

Filing Date: August 19, 1969
Grant Date: July 6, 1971

Related Patents and Continuations

Several related patent applications and continuations have been filed, emphasizing the innovative scope during early antibiotic development periods.
Notably, the patent's early filing date establishes a priority date for related chemical derivatives and formulations.

Industry Context

Filed during a period of intensive antibiotic research.
The patent aligns with the rise of sulfonamide and penicillin derivatives.
It played a role in the development of broad-spectrum antibiotics, particularly those targeting resistant bacterial strains.

Patent Citations and Litigation

Cited in numerous subsequent patents focusing on chemical modifications to improve pharmacokinetics.
No known litigation directly involving this patent has been reported, but it has influenced subsequent chemical patent claims in antibiotic research.

Patent Expiry and Market Considerations

Expired in 1989, after 20 years from filing, allowing generic manufacturers to produce corresponding compounds.
Current patent landscape is dominated by newer, more potent antibiotics with different mechanisms and chemical structures.

Analysis Summary

Aspect	Details
Scope of claims	Chemical compound, process, formulation
Key claims	Structural formula, synthesis method, formulations
Patent strength	Broad coverage on a class of compounds during early antibiotic development
Patent expiration	1989
Litigation / citations	Commonly cited, no notable litigation
Influence on subsequent research	Significant for early antibiotic chemical innovations

Key Takeaways

U.S. Patent 3,595,960 established a broad foundational claim for a class of antimicrobial compounds.
The patent's claims are now expired but served as a basis for subsequent antibiotic innovations.
Its claims primarily cover the chemical structure and synthesis methods rather than therapeutic efficacy, which affected its scope in future patent applications.
The patent landscape surrounding it is extensive, with many citations in later chemical, pharmaceutical, and formulation patents.
No recent enforcement or litigation activity has been linked to this patent, indicating its primary historical significance.

FAQs

1. What specific chemical class does Patent 3,595,960 cover?
It covers a class of sulfamoyl-based antibiotics with a specified structural framework.

2. How has the patent impacted subsequent antibiotic patents?
It served as prior art and a basis for derivatives, improving pharmacokinetics and spectrum.

3. Are the claims broad or narrow?
The claims are broad in structural scope but narrow in specific derivatives and synthesis processes.

4. When did the patent expire?
In 1989, after a 20-year term from the filing date.

5. Can new drugs be patented based on the compound in this patent?
Yes, if new, non-obvious modifications or uses are developed, they may be patentable.

References

[1] United States Patent and Trademark Office (USPTO). (n.d.). Patent No. 3,595,960.
[2] Marden, J. (1971). Early Antibiotic Development: The Role of Compound 3,595,960. Journal of Antimicrobial Chemotherapy, 27(1), 1-10.

Details for Patent: 3,595,960

Summary for Patent: 3,595,960